Status:
COMPLETED
COPD in Obese Patients
Lead Sponsor:
Voronezh N.N. Burdenko State Medical Academy
Conditions:
Copd
Obese
Eligibility:
All Genders
30-70 years
Brief Summary
The study included 176 patients with COPD. The first group included 88 normal weight patients with COPD: 71 men and 17 women, mean age 62.40 ± 8.83 years. The second group included 88 patients with CO...
Eligibility Criteria
Inclusion
- COPD diagnosis, informed consent for voluntary participation in the study
Exclusion
- patient participation in any interventional study,
- COPD exacerbation,
- concomitant lung diseases, such as confirmed or suspected malignant lung disease or other respiratory disease, such as interstitial pulmonary fibrosis, tuberculosis, sarcoidosis, bronchial asthma, bronchiectasis,
- concomitant diseases of other organs and systems, such as acute cardiovascular diseases, chronic kidney diseases and liver failure.
Key Trial Info
Start Date :
September 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2019
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04105075
Start Date
September 9 2018
End Date
September 20 2019
Last Update
October 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Voronezh State Medical University
Voronezh, Russia, 394019